Jan 27 (Reuters) - Abbott Laboratories’ quarterly profit more than doubled on Wednesday, riding on strong sales of its COVID-19 test kits and strength in its nutrition and diabetes businesses.
The company’s net earnings rose to $2.16 billion, or $1.20 per share, in the fourth quarter ended Dec. 31 from $1.05 billion, or 59 cents per share, a year earlier.
Net sales rose to $10.7 billion from $8.31 billion. (Reporting by Mrinalika Roy and Amruta Khandekar in Bengaluru; Editing by Anil D’Silva)
我们的标准: 汤森路透“信任原则”